Cochlear implantation at King Abdallah Medical City, Makkah, Saudi Arabia: Single institution experience, a 5-years retrospective analysis
- 1From the Department of Otolaryngology (Alqahtani), Alhada Armed Forces Hospital, Taif; from the Department of Otolaryngology (Almasoudi), College of medicine, Majmaah University, Al-Majmaah; from the Department of Otolaryngology (Almalki), Makkah Health Cluster; and from the Department of Otolaryngology (Badr, Alghamdi, Alghamdi), King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia.
- 0From the Department of Otolaryngology (Alqahtani), Alhada Armed Forces Hospital, Taif; from the Department of Otolaryngology (Almasoudi), College of medicine, Majmaah University, Al-Majmaah; from the Department of Otolaryngology (Almalki), Makkah Health Cluster; and from the Department of Otolaryngology (Badr, Alghamdi, Alghamdi), King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The cochlear implantation program at King Abdallah Medical Center is safe and effective for severe-to-profound hearing loss. High follow-up adherence was noted, with minor complications in this Saudi Arabian cohort.
Area Of Science
- Otolaryngology
- Neurosurgery
- Medical Device Technology
Background
- Cochlear implantation (CI) is a vital treatment for severe-to-profound hearing loss.
- Evaluating program outcomes is crucial for quality improvement and patient care.
Purpose Of The Study
- To review the outcomes of the cochlear implantation program at King Abdallah Medical Center (KAMC) in Makkah.
- To analyze patient demographics, procedural details, and complications from 2018 to 2023.
Main Methods
- Retrospective analysis of 133 patients undergoing cochlear implantation at KAMC.
- Data collection included demographics, hearing loss characteristics, imaging findings, implant types, and complications.
Main Results
- The study included 133 patients, with an average age of 9 years; 56.4% were male and 96.2% Saudi nationals.
- Med-El implants were used in 63.9% of cases, with 37.6% receiving simultaneous bilateral implants.
- Intraoperative and postoperative complications occurred in 5.3% and 8.3% of patients, respectively. Follow-up adherence was 94%.
Conclusions
- The KAMC cochlear implantation program is a safe and effective treatment for severe-to-profound hearing loss.
- Minor complications were observed, and strong follow-up adherence indicates program success.
- Continued accreditation and support are vital for the program's long-term success in hearing rehabilitation.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

